GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MRNA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Moderna stock after losing 1.39%
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Loss -1.39% PDF

The Moderna stock price fell by -1.39% on the last day (Thursday, 18th Apr 2024) from $103.44 to $102.00. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 3.61% from a day low at $99.90 to a day high of $103.51. The price has fallen in 7 of the last 10 days and is down by -0.26% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -222 thousand shares and in total, 2 million shares were bought and sold for approximately $177.59 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.75% during the next 3 months and, with a 90% probability hold a price between $103.67 and $129.49 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MRNA Signals & Forecast

There are few to no technical positive signals at the moment. The Moderna stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $104.63 and $103.92. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 09, 2024, and so far it has fallen -8.60%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Tuesday, April 09, 2024 with a target of $103.67. Despite whether the objective of the signal formation has been reached the stock may continue to fall.

Support, Risk & Stop-loss for Moderna stock

Moderna finds support from accumulated volume at $99.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.60 between high and low, or 3.61%. For the last week, the stock has had daily average volatility of 3.66%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MRNA) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Moderna Inc. to open at $101.80, and during the day (based on 14 day Average True Range), to move between $97.34 and $106.66, which gives a possible trading interval of +/-$4.66 (+/-4.57%) up or down from last closing price. If Moderna Inc. takes out the full calculated possible swing range there will be an estimated 9.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $103.85 (1.81%) than the support at $99.70 (2.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Moderna Inc. stock A Buy?

The Moderna stock holds several negative signals and despite the positive trend, we believe Moderna will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.180 Sell Candidate Unchanged

Predicted Opening Price for Moderna Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$101.80 ( 0.194%) $102.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MRNA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 105.41 3.34 %
R2 104.03 1.99 %
R1 103.18 1.16 %
Current price: 102.00
Support S1 100.42 -1.54 %
S2 99.57 -2.38 %
S3 98.20 -3.73 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 111.98 9.78 %
R2 111.60 9.41 %
R1 103.85 1.81 %
Current price 102.00
Support S1 99.70 -2.25%
S2 99.44 -2.51%
S3 87.41 -14.30%

FAQ

What is the symbol for Moderna Stock and on which exchange is it traded?
The symbol for Moderna is MRNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Moderna Stock?
The Moderna stock holds several negative signals and despite the positive trend, we believe Moderna will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Moderna Stock?
Moderna Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Moderna Stock.

What's the current price of Moderna Stock?
As of the end of day on the 2024-04-18, the price of an Moderna (MRNA) share was $102.00.

What is the 52-week high and low for Moderna Stock?
The 52-week high for Moderna Stock is $144.43 and the 52-week low is $62.55.

What is the market capitalization of Moderna Stock?
As of the 2024-04-18, the market capitalization of Moderna is 39.605B.

When is the next earnings date for Moderna?
The upcoming earnings date for Moderna is May 02, 2024.
Click to get the best stock tips daily for free!

About Moderna Inc.

Moderna Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus... MRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT